| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
| | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
| Revenues: |
| Shared Services and Other | 4.0 | 11.9 | 15.1 | | | | | |
| Other | 295.5 | 248.0 | 206.3 | | | | | |
| Total revenues [+] | 299.5 | 259.9 | 221.4 | 284.7 | 204.3 | 133.5 | 94.8 | 70.0 |
| Products | | | | | | | | 60.1 |
| Services | | | | | | | | 10.0 |
| Revenue growth [+] | 15.3% | 17.4% | -22.2% | 39.4% | 53.0% | 40.8% | 35.3% | 44.6% |
| Shared Services and Other | -66.0% | -21.5% | | | | | | |
| CareVention HealthCare | 19.1% | 20.2% | 12.7% | 32.4% | | | | |
| Cost of goods sold [+] | 232.6 | 193.4 | 160.6 | 181.4 | 137.7 | 93.7 | 65.2 | 49.1 |
| Cost of product sales | | | | | | | | 45.8 |
| Cost of services, excluding D&A | | | | | | | | 3.3 |
| Gross profit | 66.9 | 66.5 | 60.8 | 103.4 | 66.6 | 39.8 | 29.6 | 20.9 |
| Gross margin | 22.3% | 25.6% | 27.4% | 36.3% | 32.6% | 29.8% | 31.2% | 29.9% |
| Selling, general and administrative [+] | 85.5 | 74.1 | 63.2 | 76.2 | 37.8 | 26.7 | 15.7 | 10.0 |
| Sales and marketing | 10.5 | 11.0 | 8.1 | 25.3 | 9.7 | 5.5 | 3.9 | 2.9 |
| General and administrative | 75.0 | 63.1 | 55.1 | 50.9 | 28.2 | 21.2 | 11.9 | 7.1 |
| Research and development | 14.5 | 14.6 | 14.4 | 21.7 | 12.2 | 5.6 | 3.8 | 2.9 |
| Other operating expenses | 3.7 | | | 3.8 | 49.5 | -6.2 | -0.3 | -2.1 |
| Adjusted EBITDA | 7.5 | 43.4 | 44.1 | 28.9 | -22.6 | 22.4 | 14.6 | 10.7 |
| Adjusted EBITDA margin | 2.5% | 16.7% | 19.9% | 10.2% | -11.1% | 16.8% | 15.4% | 15.2% |
| Stock-based compensation | 36.8 | 38.5 | 32.6 | 27.3 | 10.4 | 8.8 | 4.3 | 0.6 |
| EBITDA [+] | -29.4 | 5.0 | 11.5 | 1.6 | -32.9 | 13.7 | 10.4 | 10.1 |
| EBITDA growth | -691.2% | -56.9% | 607.8% | -104.9% | -341.3% | 31.3% | 2.9% | 424.8% |
| EBITDA margin | -9.8% | 1.9% | 5.2% | 0.6% | -16.1% | 10.2% | 11.0% | 14.4% |
| Depreciation | 23.6 | 40.1 | 38.5 | 8.6 | 5.7 | 3.9 | 2.4 | 1.6 |
| EBITA | -53.0 | -35.2 | -27.0 | -7.0 | -38.6 | 9.8 | 8.0 | 8.5 |
| EBITA margin | -17.7% | -13.5% | -12.2% | -2.4% | -18.9% | 7.3% | 8.5% | 12.1% |
| Amortization of intangibles | 7.0 | 7.6 | 6.5 | 25.7 | 11.2 | 5.6 | 2.7 | 2.3 |
| EBIT [+] | -60.0 | -42.7 | -33.5 | -32.6 | -49.7 | 4.1 | 5.3 | 6.2 |
| EBIT growth | 40.5% | 27.5% | 2.7% | -34.4% | -1301.4% | -21.6% | -14.4% | 5661.7% |
| EBIT margin | -20.0% | -16.4% | -15.1% | -11.5% | -24.3% | 3.1% | 5.6% | 8.8% |
| Non-recurring items [+] | 8.9 | | 7.7 | | | | | |
| Asset impairment | 8.9 | | 5.0 | | | | | |
| Unusual expense | | | 2.6 | | | | | |
| Interest expense | 9.0 | 9.1 | 20.7 | 16.0 | 0.9 | 0.7 | 4.5 | 5.9 |
| Interest expense | 9.0 | 9.1 | 20.7 | 16.0 | 0.9 | 0.7 | 4.5 | 5.9 |
| Other income (expense), net [+] | 1.1 | | | | | | -5.8 | -2.8 |
| Gain (loss) on debt retirement | | | | | | | -6.4 | |
| Change in fair value of warrants | | | | | | | -0.6 | 2.8 |
| Change in value of contingent liability | | | | 3.8 | 49.5 | -6.2 | -0.3 | -2.1 |
| Other | 1.1 | | | | | | | |
| Pre-tax income | -76.9 | -51.8 | -61.9 | -48.6 | -50.6 | 3.5 | -5.0 | -2.5 |
| Income taxes | 0.4 | 0.4 | -5.4 | -16.2 | -3.4 | -9.3 | 0.5 | 0.3 |
| Tax rate | | | 8.7% | 33.3% | 6.7% | | | |
| Earnings from continuing ops | -77.3 | -52.2 | -56.5 | -32.4 | -47.3 | 12.8 | -6.2 | -12.8 |
| Earnings from discontinued ops | -70.2 | -26.8 | -24.5 | | | | | |
| Net income | -147.5 | -79.1 | -81.0 | -32.4 | -47.3 | 12.8 | -6.2 | -12.8 |
| Net margin | -49.2% | -30.4% | -36.6% | -11.4% | -23.1% | 9.6% | -6.5% | -18.3% |
| |
| Basic EPS [+] | ($3.18) | ($2.24) | ($2.59) | ($1.57) | ($2.48) | $0.76 | ($0.82) | ($2.97) |
| Growth | 41.9% | -13.4% | 64.7% | -36.5% | -423.7% | -192.9% | -72.3% | 141.2% |
| Diluted EPS [+] | ($3.18) | ($2.24) | ($2.59) | ($1.57) | ($2.48) | $0.68 | ($0.53) | ($2.97) |
| Growth | 41.9% | -13.4% | 64.7% | -36.5% | -463.3% | -228.2% | -82.1% | 141.2% |
| |
| Shares outstanding (basic) [+] | 24.3 | 23.3 | 21.8 | 20.6 | 19.1 | 16.7 | 7.5 | 4.3 |
| Growth | 4.3% | 6.8% | 5.8% | 8.0% | 14.2% | 123.5% | 73.3% | 6.6% |
| Shares outstanding (diluted) [+] | 24.3 | 23.3 | 21.8 | 20.6 | 19.1 | 18.8 | 11.6 | 4.3 |
| Growth | 4.3% | 6.8% | 5.8% | 8.0% | 1.7% | 62.0% | 168.4% | 6.6% |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |